Form 26AS evidence requires successor-entity accounting verification after business transfer, while invoice-supported related-party advertising expend...
Money-laundering judgment timing requires awaiting the scheduled-offence decision despite continuation of the underlying trial where outcomes directly...
Accredited investor eligibility expands through securities-market exposure, while alternative investment fund disputes require prescribed resolution a...
CESTAT determined classification of imported glucose monitoring devices under CTH 9027 80 90, affirming prior judicial precedents from Bayer Pharmaceuticals case and Bombay HC ruling. The tribunal upheld classification under scientific instrument heading, which qualifies for NIL Basic Customs Duty (BCD) under Notification No. 24/2005-Cus. The revenue's appeal was dismissed, confirming the concessional duty rate for goods classified under CTH 9027, distinguishing them from medical instruments under CTH 9018. The decision reinforces the specific tariff classification principles for medical diagnostic equipment, granting the appellant the benefit of zero customs duty based on the precise product categorization.
CESTAT determined classification of imported glucose monitoring devices under CTH 9027 80 90, affirming prior judicial precedents from Bayer Pharmaceuticals case and Bombay HC ruling. The tribunal upheld classification under scientific instrument heading, which qualifies for NIL Basic Customs Duty (BCD) under Notification No. 24/2005-Cus. The revenue's appeal was dismissed, confirming the concessional duty rate for goods classified under CTH 9027, distinguishing them from medical instruments under CTH 9018. The decision reinforces the specific tariff classification principles for medical diagnostic equipment, granting the appellant the benefit of zero customs duty based on the precise product categorization.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4915 
